Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba 260-8670, Japan.
Department of Ophthalmology, School of Medicine, International University of Health and Welfare, 4-3 Kozunomori, Narita 286-8686, Japan.
Int J Mol Sci. 2023 Aug 18;24(16):12919. doi: 10.3390/ijms241612919.
Diabetic retinopathy (DR) is a major complication of diabetes and a leading cause of blindness worldwide. DR was recently defined as a neurovascular disease associated with tissue-specific neurovascular impairment of the retina in patients with diabetes. Neurovascular cell death is the main cause of neurovascular impairment in DR. Thus, neurovascular cell protection is a potential therapy for preventing the progression of DR. Growing evidence indicates that a variety of cell death pathways, such as apoptosis, necroptosis, ferroptosis, and pyroptosis, are associated with neurovascular cell death in DR. These forms of regulated cell death may serve as therapeutic targets for ameliorating the pathogenesis of DR. This review focuses on these cell death mechanisms and describes potential therapies for the treatment of DR that protect against neurovascular cell death.
糖尿病视网膜病变(DR)是糖尿病的主要并发症,也是全球致盲的主要原因。最近将 DR 定义为一种与糖尿病患者视网膜特定的神经血管损伤相关的神经血管疾病。神经血管细胞死亡是 DR 中神经血管损伤的主要原因。因此,神经血管细胞保护是预防 DR 进展的一种潜在治疗方法。越来越多的证据表明,多种细胞死亡途径,如细胞凋亡、坏死性凋亡、铁死亡和细胞焦亡,与 DR 中的神经血管细胞死亡有关。这些形式的调节性细胞死亡可能成为改善 DR 发病机制的治疗靶点。本综述重点介绍这些细胞死亡机制,并描述了针对保护神经血管细胞免于死亡的 DR 治疗的潜在疗法。